Antiarrhythmic peptides enhance gap junction current in pairs of cardiomyocytes and coupling in cardiac tissue. To elucidate the underlying mechanisms, we investigated the effects of the antiarrhythmic peptide AAP10 (GAG-4Hyp-PY-CONH 2 ) on pairs of adult guinea pig ventricular cardiomyocytes and pairs of HeLa cells transfected with rat cardiac connexin 43 (Cx43). By using a double-cell voltage-clamp technique in pairs of cardiomyocytes, we found that under control conditions the gap junction conductance (g j ) steadily decreased with time (by −0.292 ± 0.130 nS/min). Use of 50 nmol/L AAP10 reversed this rundown and increased g j (by +0.290 ± 0.231 nS/min, P<0.05). This effect of AAP10 could be significantly antagonized by bisindolylmaleimide I (BIM) and by the protein kinase C (PKC) subtype-specific inhibitor CGP54345 (PKCα). In HeLa-Cx43 cells, AAP10 exerted the same electrophysiological effect. In these cells, AAP10 activated PKC (determined by using ELISA) in CGP54345-sensitive manner and significantly enhanced incorporation of 32 P into Cx43 with dependence on PKC. If G-protein coupling was inhibited with 1 mM GDP-βS, we found the effects of AAP10 on 32 P incorporation were also completely abolished. Next, we performed a radioligand binding study with 14 C-AAP10 as radioligand and AAPnat as competitor. We found saturable binding of 14 C-AAP10 to cardiac membrane preparations, which could be displaced with AAPnat. The K d of AAP10 was 0.88 nmol/L. We conclude that 1) AAP10 increases g j both in adult cardiomyocytes and in transfected HeLa-Cx43 cells, 2) AAP10 exerts its effect via enhanced PKC-dependent phosphorylation of Cx43, 3) AAP10 activates PKCα, and 4) a membrane receptor exists for antiarrhythmic peptides in cardiomyocytes. One of the most abundant connexins is connexin 43 (Cx43) [1] . Although intact communication seems essential for normal organ function, failure of gap junction communication can cause malfunction of certain organs, e.g., arrhythmias in the heart [2-5]; a certain peripheral nervous disease, the X-chromosomal Charcot-Marie-Tooth syndrome [6] ; or transition from a carcinoma in situ to an invasively growing tumor [7] . Moreover, Loewenstein [8] emphasized the importance of intercellular communication for growth and differentiation control. Consequently, approaches to substances influencing gap junction coupling are of general interest for biomedical research.
One of the most abundant connexins is connexin 43 (Cx43) [1] . Although intact communication seems essential for normal organ function, failure of gap junction communication can cause malfunction of certain organs, e.g., arrhythmias in the heart [2] [3] [4] [5] ; a certain peripheral nervous disease, the X-chromosomal Charcot-Marie-Tooth syndrome [6] ; or transition from a carcinoma in situ to an invasively growing tumor [7] . Moreover, Loewenstein [8] emphasized the importance of intercellular communication for growth and differentiation control. Consequently, approaches to substances influencing gap junction coupling are of general interest for biomedical research.
A group of peptides derived from a natural antiarrhythmic peptide [9] has been described to act antiarrhythmically [10] and to suppress a certain type of ventricular fibrillation (AAP10: GAG4Hyp-PY-CONH 2 [4] ; and HPP-5: N-3-(4-hydroxyphenyl)-propionyl-Pro-Hyp-Gly-Ala-Gly-OH [11, 12] ). The molecular mechanism of action of these peptides, however, remained to be elucidated. The question of the transduction of the AAP10 effect is of general interest, because many other cells besides cardiomyocytes couple via Cx43 gap junctions. We choose freshly isolated adult guinea pig cardiomyocytes (which are predominantly coupled via Cx43) as a model, as well as HeLa cells transfected with Cx43 as a simplified cell culture model allowing quantitative biochemical measurements [13] .
MATERIALS AND METHODS
All animal experiments were performed in accordance with the German laws for animal welfare and were approved by the local committee for animal welfare.
Cell isolation
Male adult guinea pigs (250-350 g, Fa. Rollié, Lengerich, Germany) were killed, and the hearts were quickly removed, transferred to a Langendorff apparatus, and perfused with modified Tyrode solution (composition [ room temperature (RT; 21°C). Thereafter, the temperature was set to 37°C, and hearts were perfused for 2 min with Ca . The ventricles were minced, incubated in collagenase solution for another 5-10 min, and filtered through nylon gauze (mesh width 250 µm). After resuspension, a cell pellet was obtained by centrifugation (100g, 1 min). Thereafter, the [Ca glass dishes with Dulbecco's modified Eagle's medium cell culture medium, supplemented with 10% FCS, 1 µg/ml puromycin, 100 µg/ml penicillin, and 100 µg/ml streptomycin in a 10% CO 2 atmosphere.
Double-cell voltage clamp
The method for double-cell voltage-clamp assessment of the gap junctional conductance has been described previously [14, 15] . Thus, we give here only a brief description of the method.
For the double-cell voltage clamp we used two switch clamp amplifiers (SEC 05, switching frequency 30 kHz; npi electronic, Tamm, Germany), which allow accurate measurement of gap junction conductance (g j ) independent of serial resistance, with an error less than 5% [15] . Data were sampled at 1-10 kHz by using eggworks software (npi electronic). For analysis, data were low-pass filtered at 1 kHz. Cells were transfered to a 1-ml perfusion chamber mounted on the stage of an inverted microscope (Zeiss, Jena, Germany) and were superfused (1 ml/min) with Tyrode solution supplemented with 1 mM BaCl 2 to block the K + conductance. Each cell of a pair was connected to the headstage of an amplifier via glass suction pipettes (resistance 2-5 MΩ, filled with "intracellular" solution, containing [mM]: CsCl 125, NaCl 8, CaCl 2 1, EGTA 10, Na 2 -ATP 2, Mg-ATP 3, Na 2 -GTP 0.1, HEPES 10, pH 7.2, with CsOH). If seal resistance exceeded 3 GΩ, measurements were started 3-5 min after establishing the whole cell patch configuration. Holding potential was adjusted to −40 mV. Membrane resistance and capacitance were measured by a 200-ms voltage step from −40 to −50 mV as described by Sontheimer [16] . For the subsequent experiments, both cells were kept at a holding potential of −40 mV. Then the potential of one cell was changed for 200 ms to potentials ranging from −90 to +10 mV in steps of 10 mV, thus applying transjunctional voltage gradients ranging from −50 to +50 mV. The current elicited in the nonpulsed cell was taken as the gap junction current as described earlier [15, [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] . The current-voltage relationships were always linear, and g j was calculated as the slope by linear regression. Measurements were repeated every 60 s for a total period of 70 min.
The following series of experiments were performed by using pairs of freshly isolated guinea pig cardiomyocytes; each experiment started after 30 min of equilibration under standard conditions (i.e., superfusion with Tyrode solution). After this equilibration period (the control period), either vehicle (n=9) or 10 nmol/L (n=6) or 50 nmol/L (n=6) AAP10 (n=6) was added to the superfusion solution and applied until the end of the experiment. In another series of experiments, the protein kinase C (PKC) inhibitor bisindolylmaleimide I (BIM, 0.2 µM), which inhibits the classical isoforms of PKC (i.e., PKCα, -β, -γ, and -δ) [19] , was added to the pipette solution (n=6). In these experiments, 50 nmol/L AAP10 was applied after 30 min of equilibration. To study the subtypes of PKC involved, we performed an additional series of experiments: after the equilibration period, either the vehicle (n=6) or 50 nmol/L AAP10 (n=6) or 50 nmol/L AAP10 in the presence of 10 µM CGP54345, the PKCα-specific inhibitor [20] (n=6), was applied for 30 min.
To investigate whether the effect of AAP10 can also be observed in cells expressing Cx43, we performed another experimental series with HeLa-Cx43 cells: after 15 min of equilibration (as described above), 50 nmol/L AAP10 (n=5) was applied for 30 min using the patch-clamp protocol described above.
We also studied voltage-dependent inactivation in these cells by application of 5-s pulses to establish transjunctional voltages ranging from −100 to +100 mV. We determined both the instantaneous and the steady-state g j and calculated the ratio steady-state g j /instantaneous g j (G jss /G jinst ), as described in the literature [21] .
Protein kinase C assay
To measure the effect of AAP10 on PKC activity, the Protein Kinase Assay Non-radioactive Kit from Calbiochem (Calbiochem-Novabiochem, San Diego, CA) was used according to the manufacturer's instructions. Confluent cultures of HeLa-Cx43 cells were incubated with 1) vehicle, 2) 50 nmol/L AAP10, 3) 50 nmol/L AAP10 and 10 µM CGP54345, or 4) 10 µM CGP54345, in PBS for 30 min at 37°C. The stimulations were quenched by cold PBS. The cells were washed three times with ice-cold PBS and collected in cold sample preparation buffer (50 mM Tris-HCl, 50 mM β-mercaptoethanol, 10 mM benzamidine, 5 mM EGTA, 10 mM EDTA, and 1 mM phenylmethylsulfonyl fluoride [PMSF], pH 7.5). The samples were sonicated for 1 min on ice and were centrifuged at 100,000g for 60 min at 4°C. The supernatant was saved, with fresh samples used for assays. The protein concentration was determined by using a standard protocol [22] . Samples of 10 µg of total protein were used for the assay performed in PKCpseudosubstrate-coated wells of a 96-well plastic plate at 25°C. Enzyme activity was visualized with o-phenylenediamine, and the results were monitored by using an automatic ELISA plate reader (λ = 492 nm). The optical density (O.D.) values were normalized to those under control conditions, which were set to 100%. The results are presented as means ± SE of three different preparations.
Western blot analysis of Cx43
HeLa-Cx43cells were solubilized in Laemmli buffer according to classical protocols. Lysates were centrifuged (13,000g, 10 min at 4°C), and supernatants were saved. For electrophoresis, 20 µg of total protein was loaded and resolved in 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Proteins were transferred electrically to nitrocellulose ECL (enhanced chemiluminescence) membranes (Amersham Pharmacia, Buckinghamshire, UK) using the tank transfer system (Bio-Rad, München, Germany). After membranes were blocked (Roti-block, Roth, Karlsruhe, Germany), they were subsequently incubated with a monoclonal anti-Cx43 antibody raised against amino acid residues 250-272 of rat Cx43 (Chemicon, Temecula, CA) and secondary antibody coupled to peroxidase (Sigma, St. Louis, MO). ECL detection was performed with SuperSignal reagent (Pierce, Rockford, IL). Immunoblots were exposed to X-ray film, scanned (Twain, Tualatin, OR), and analyzed using TINA software (Isotopenmessgeraete GmbH, Berlin, Germany). Phosphorylation of Cx43 can also be clearly detected by the appearance of a slower migrating Cx43 immunopositive band in the blots [23] . We determined, by densitometric means, the ratio between the phosphorylated and nonphosphorylated Cx43 in these immunoblots [as previously described; see ref 24] .
P Phosphorylation of Cx43
In addition, incorporation of 32 P into Cx43 was investigated in HeLa-Cx43 cells. Therefore, confluent cultures of HeLa-Cx43 cells were incubated in phosphate-free medium for 15 min and were then exposed to 0.05 mCi/ml H 3 32 PO 4 for 4 h [adapted from ref 25] . Thereafter, cells were exposed to vehicle (n=3), to 50 nmol/L AAP10 (n=3), or to 50 nmol/L AAP10 + 2 µM BIM (n=3) for 15 min at 37°C. After cells were harvested, membrane proteins were prepared (cells were homogenized by ultrasound sonication) and centrifuged at 20,000g for 30 min at 4°C; the pellet was resuspended in 1% Triton X-100 and centrifuged at 15,000g, thereafter at 106,000g for 60 min. The resulting pellet was resuspended in sample buffer, and 20 µg of protein/slot samples were separated on 12.5% SDS-PAGE and blotted onto a nitrocellulose membrane. Cx43 was detected by using the monoclonal anti-rCx43 antibody (24 h, 4°C) and a secondary alkaline phosphatase-labeled anti-mouse IgG antibody (1 h, RT), stained according to classical protocols for identification of the Cx43 band. The final Western blot was then used for autoradiography on X-ray film, and 32 P incorporation within the Cx43 band was determined by using computerassisted densitometry.
In another experimental protocol, we investigated whether the action of AAP10 might depend on G-protein. Therefore, after the cells were loaded with 32 P, G-proteins were inactivated by 1 mM GDP-βS, which was transported into the cells via liposome transfer (lipofectamine), for 2 h at 37°C. Thereafter, cells were treated either with vehicle (n=3) or with 50 nmol/L AAP10 (n=3) for 15 min and processed as described. Liposome transfer was confirmed with liposomes containing Lucifer yellow.
Radioligand binding study
To search for a possible receptor for antiarrhythmic peptides, we performed a classical binding study [26] using 14 C-AAP10 as the radioligand and the AAP10 analogue AAP11TT (VAGHypPY) or AAPnat (GPHypGAG) as a heterologous competitor in a homogenate of adult rabbit ventricles. Ventricles from adult rabbit hearts (male rabbits weighing 2500 g, Fa. Rollié) were homogenized in 10 volumes of ice-cold 1 mmol/L KHCO 3 with an Ultra Turrax (Janke and Kunkel, Staufen, Germany), diluted to 20 ml with 1 mmol/L KHCO 3 , centrifuged at 700g for 15 min, passed through four layers of cheesecloth, and centrifuged again at 50,000g for 20 min. Pellets were washed once by resuspension, followed by recentrifugation, and were finally resuspended in incubation buffer (10 mmol/L Tris-HCl, 154 mmol/L NaCl, 0.55 mmol/L ascorbic acid, pH 7.4, 25°C) with addition of protease inhibitors (1 U/min aprotinin, 1 µM leupeptin, 1 µM pepstatin A, 1 µM PMSF) at a protein concentration of 0.5 mg/ml. Protein content was determined by the method of Bradford [27] using bovine IgG as a standard.
As a control, we performed experiments to test the binding protocol by measuring total binding of 10 −7 mol/L 14 C-AAP10 depending on the incubation time (from 2 to 200 min) at different temperatures (4°C, 21°C [or RT], 37°C). We found that binding reached an equilibrium after 30 min of incubation at RT. This protocol was used for the subsequent binding assay.
The density of AAP10 receptors in cardiac membranes was determined by 14 C-AAP10 binding at 10 concentrations ranging from 10 −11 to 10 −4 mol/L for 30 min at RT, followed by rapid vacuum filtration, resuspension in scintillation cocktail (Aqualuma, Amersham, Braunschweig, Germany), and β-counting. Nonspecific binding of 14 C-AAP10 was defined as binding to membranes not displaceable by AAP11TT (0.5 µM). Specific binding was defined as total binding minus nonspecific binding and was normally about 20-30% at 10 nmol/L 14 C-AAP10.
In a second series of experiments, displacement of 5 × 10 −5 mol/L 14 C-AAP10 by increasing concentrations of AAPnat (10 −11 to 10 −4 mol/L, 10 steps) was investigated. AAPnat competition curves were analyzed by using the iterative curve-fitting program InPlot (GraphPad Software, San Diego, CA). Statistical analysis was performed by using the F ratio test to measure the goodness of fit of the competition curves for either one or two binding sites. Each binding experiment was repeated three times, and each measurement was executed twice.
Chemical cross-linking
To isolate the putative receptor, chemical cross-linking was performed by incubating a homogenate of rabbit ventricle with 1 µM (FITC-Lys) 3 -NH-(CH 2 ) 5 -CO-GAG-Hyp-PY-CONH 2 (or fluorescein isothiocyanate [FITC]-labeled AAP10) and 2 µM of the cross-linking agent disuccinimidylsuberate (DSS) at 4°C in PBS (pH 7.5) for 2 h according to classical protocols. The reaction was stopped by 2 nmol/L Tris for 15 min, the solution was centrifuged at 20,000g for 60 min (4°C), and the resulting pellet was resuspended and centrifuged at 100,000g (60 min, 4°C). The pellet was separated by using 12.5% SDS-PAGE, and the molecular weight was determined by fluorography.
As an additional control, the same protocol was repeated with 14 C-AAP10 as the ligand, with the final cross-linking product being detected by SDS-PAGE and autoradiography.
Affinity chromatography
We synthesized agarose-N-AAP10 from agarose-N-Gly-COOH and HOOC-Ala-Gly-Hyp-ProTyr-CONH-resin in dimethylformamide as matrix material for affinity chromatography. The homogenate from rabbit ventricle was centrifuged at 20,000g (60 min, 4°C), resuspended in 3-[(3-cholamidopropyl)dimethylammonio]-1-propane sulfonate (CHAPS)-containing solubilization buffer, and centrifuged at 100,000g (60 min, 4°C). The supernatant containing membrane proteins was resuspended in saline at pH 7.4 and incubated on the column (10-ml column consisting of the agarose-N-AAP10 matrix) for 10 min. Thereafter, the column was diluted with 10 ml of saline (pH 7.4), followed by perfusion with saline at pH 6.5. Twenty fractions of 1 ml each were collected and separated on 12.5% SDS-PAGE.
Chemicals
All chemicals were of analytical grade and were purchased from Sigma (Deisenhofen, Germany) except AAP10 peptide (GAG-4Hyp-PY-CONH 2 ), which was synthesized in our laboratory as described [28] and purified using high-pressure liquid chromatography (purity >99%). The following peptides were synthesized: AAP10 (GAG-4Hyp-PY-CONH 2 ), 14 C-AAP10 ( 14 C-GAG4Hyp-PY-CONH 2 ), AAP11TT (Val-Ala-Gly-Hyp-Pro-Tyr-CONH 2 ), AAPnat (Gly-Pro-HypGly-Ala-Gly). BIM was obtained from Alexis (Grünberg, Germany). CGP54345 was kindly provided by Dr. Fuhrer from Novartis (Basel, Switzerland). Lipofectamine was purchased from Life Technologies (Karlsruhe, Germany). The cross-linking agent DSS was purchased from Pierce.
Statistics
All values are given as means ± SE of n experiments. Data were analyzed by using ANOVA followed by a two-sided Wilcoxon or Mann-U-Whitney test at a level of significance of P < 0.05 or by a post-hoc Tukey HSD test corrected for multiple comparisons.
RESULTS

AAP10 enhances gap junction conductance in cardiomyocytes
When we applied transcellular voltages of −50 to +50 mV (200-ms pulses) to pairs of adult guinea pig cardiomyocytes, a linear current-voltage relationship became obvious (Fig. 1 ) from which the g j could be calculated via linear regression analysis. The initial g j was 35.4 ± 4 nS (n=18). There were no significant differences between the experimental series regarding the initial values of these parameters. This initial g j is in the range of reported g j for pairs of adult guinea pig cardiomyocytes (ranging from 25 to 3900 nS [29] [30] [31] depending on the pipette solution and on the cell isolation protocol [32] ). We found that during equilibration under control conditions, g j continuously decreased with time. In the control series (treatment with vehicle), this time-dependent decrease in g j was −0.292 ± 0.130 nS/min (n=6; P<0.05) during a period of 70 min ( Figs. 2A and 3A) , starting from an initial g j of 34.8 ± 5 nS (n=6).
The time-dependent decline in g j could be completely prevented by application of 50 nmol/L AAP10 (Fig. 2B) ; 10 nmol/L AAP10 was also effective, but less so (data not shown). The initial g j in this series of experiments was 37.9 ± 3 nS (n=6) and (as in the control series) significantly declined during the first 30 min, i.e., without AAP10, by −0.222 ± 0.123 nS/min (n=6; not significant vs. control). However, after application of 50 nmol/L AAP10 this decline reversed, and in contrast we found an increase in g j by +0.290 ± 0.231 nS/min (n=6) (Figs. 2B and 3A; P<0.05). The effect of AAP10 could be completely washed out within 20 min (data not shown).
Effect of AAP10 on gap junction conductance in cardiomyocytes depends on PKCα
The effect of 50 nmol/L AAP10 was completely and significantly blocked when BIM (0.2 µmol/L) was present in the pipette solution. In that series of experiments, the initial g j was 33.5 ± 4 nS (n=6), and during the control period (first 30 min, without AAP10) it significantly decreased by −0.410 ± 0.07 nS/min (n=6; Fig. 3A; P<0.05 ). This decrease was somewhat accelerated as compared with the series without BIM but without reaching a statistically significant difference. If under these conditions, i.e., in the presence of BIM, 50 nmol/L AAP10 was applied, AAP10 did not significantly alter the decrease in g j (−0.295 ± 0.05 nS/min; n=6; not significant vs. the control period before AAP10, but P<0.05 vs. AAP10 alone, without BIM) (Fig. 3A) .
Using the PKC subtype-specific inhibitor CGP54345, we found that the AAP10 effect, i.e., the inhibition of the time-dependent decrease in g j , could also be significantly antagonized by CGP54345 (P<0.05): from an initial conductance of 55 ± 5 nS g j constantly decreased with time by −0.400 ± 0.180 nS/min (n=6) under control conditions. When 50 nmol/L AAP10 was applied in the presence of CGP54345 (in the pipette), we found a similar time-dependent decrease in g j . Thus, PKC inhibition with CGP54345 antagonized the effect of AAP10 (P<0.05 vs. AAP10 alone) (Fig. 3A) .
AAP10 exerts similar electrophysiological effects on HeLa-Cx43 cells
In HeLa-Cx43 cells a similar effect of AAP10 became obvious: from an initial value of 11.4 ± 2.5 nS, g j decreased by −0.313 ± 0.111 nS/min in a time dependent fashion. Similar to the experiments on cardiomyocytes, this time-dependent decrease in g j was significantly reversed after application of 50 nmol/L AAP10, and g j increased by +0.078 ± 0.034 nS/min (P<0.05) during a period of 30 min (Fig. 3B) .
Because from the experiments described above it was unclear whether AAP10 may affect voltage-dependent inactivation of Cx43 channels, we systematically investigated this question in HeLa-Cx43 cells. Under control conditions, we found the typical symmetrical voltage dependence when plotting the ratio of steady-state g j /instantaneous g j (G jss /G jinst ) vs. the transjunctional voltage (Fig. 3C ). This was not altered by 50 nmol/L AAP10 (a 30-min treatment) (Fig. 3C ).
AAP10 activates protein kinase C (measured by use of ELISA)
We found that AAP10 induced a twofold increase in PKC activity in HeLa-Cx43 cells (Fig. 4A) . The AAP10-induced stimulation of the enzyme could be completely prevented by addition of the specific PKCα inhibitor CGP54345 [20] (10 µM) to the cells: PKC activity in HeLa-Cx43 cells treated simultaneously with AAP10 and CGP54345 was not different from the control level. The basal PKC activity in the cells treated with CGP54345 alone was slightly (but not significantly) reduced in comparison to untreated control cultures (Fig. 4A ).
AAP10 induces phosphorylation of Cx43
Incubation of HeLa-Cx43 cells with 32 P resulted in radioactive labeling of Cx43. Thus, under control conditions, i.e., in the absence of AAP10, we found that the Cx43 band was significantly labeled with 32 P, and we detected 650 ± 20 densitometric units by autoradiography. Under the influence of 50 nmol/L AAP10, the incorporation of 32 P into Cx43 was significantly enhanced (600 ± 20 vs. 1269 ± 30 densitometric units). This AAP10-induced incorporation of 32 P into Cx43 was completely prevented by the PKC inhibitor BIM (496 ± 20 densitometric units) (Fig.  4B ).
In the second series of experiments, i.e., in the presence of GDP-βS, radioactive labeling of Cx43 was 1233 ± 30 densitometric units, via autoradiography, in the absence of AAP10. In the presence of 50 nmol/L AAP10, the labeling of Cx43 was unchanged (1066 ± 30 densitometric units) (Fig. 4B ).
In addition, increased phosphorylation of Cx43 could be observed from the appearance of the slower migrating isoform in Western blots (Fig. 4C) . We determined the ratio between the slower migrating band of the phosphorylated (P-Cx43) and the nonphosphorylated (NP-Cx43) bands of Cx43. For this ratio we found-in accordance with the enhanced 32 P incorporationthat this ratio P-Cx43/NP-Cx43 was enhanced by AAP10 from 1.4 ± 0.2 to 4.65 ± 0.3. This effect of AAP10 was also completely blocked by BIM (ratio: 1.4 1 ± 0.2). In the presence of GDP-βS, the AAP10 effect was again abolished (ratio: 4.71 ± 0.4 without AAP10 vs. 4.57 ± 0.4 with AAP10).
AAP10 binds to a membrane protein (radioligand binding)
Incubation of a cardiac membrane preparation with 10 (Fig. 5B) .
A 200-kDa membrane protein binds to AAP10 in experiments using affinity chromatography and chemical cross-linking
Finally, we attempted to isolate this binding protein by using affinity chromatography and chemical cross-linking (Fig. 6 ). After separation of rabbit cardiac membrane proteins on the affinity chromatography column (using AAP10-agarose), and fractionated elution (20 fractions of 1 ml each), we found a 200-kDa protein band in SDS-PAGE fraction 5 (and to a lesser extent in fractions 3-4 and 6-7) (Fig. 6B) . A second very weak band was found at 84 kDa.
For a control, we incubated FITC-labeled AAP10 with rabbit cardiac membrane proteins in the presence of the cross-linker DSS and separated the solution using SDS-PAGE (see Materials and Methods). We found a single fluorescent band at 200 kDa. This could also be reproduced by using 14 C-AAP10 as the radioligand (Fig. 6A ).
DISCUSSION
The results of our study demonstrate that 1) AAP10 increases g j both in adult cardiomyocytes and in transfected HeLa-Cx43 cells, 2) AAP10 activates PKC, 3) AAP10 leads to enhanced phosphorylation of Cx-43, 4) the effects of AAP10 on g j , Cx43 phosphorylation, and PKC activity are sensitive to treatment with PKC inhibitors, 5) PKCα is involved the AAP10-induced increase in g j , and 6) specific binding of antiarrhythmic peptides to a membrane protein exists.
Our double-cell voltage-clamp experiments indicated a time-dependent rundown of g j in good agreement with the observations of others [33] . The common explanation for this g j rundown is a dephosphorylation of the connexins [33] [34] [35] , which might be due to inhibition of protein kinases or to activation of phosphatases [35] , or to a loss of ATP [32] . The last can usually be overcome by addition of ATP to the pipette solution (as commonly used and as used in this study), in concentrations corresponding the physiological intracellular level of 3-7.5 mM [36] . Our results demonstrate that AAP10 treatment reverses this rundown. Because this was also seen in HeLa cells, which are much smaller than cardiomyocytes, an artifact related to space clamp problems does not seem to play a role. Because PKC is often involved in regulation of g j [37] [38] [39] , we tested the influence of the PKC inhibitor BIM (0.2 µM, in the pipette; this agent is reported in the literature to be specific for inhibition of the PKC isoforms α, β, δ, and γ [19] ) on AAP10 effects on g j . It became obvious from our results that the AAP10 effect on g j was completely abolished by BIM. Similarly, the PKCα subtype-specific inhibitor CGP54345 [20] completely suppressed the effect of AAP10 on g j . Taken together, results from these electrophysiological experiments using BIM and CGP54345 support the idea that the effect of AAP10 on g j involves PKC. The findings using CGP54345 suggest that the effect may be mediated by PKCα. The biochemical experiments on the activation of PKC (PKC assay) showing complete inhibition of the AAP10-induced activation of PKC by CGP54345 further support the idea that AAP10 activates PKCα.
Adult guinea pig ventricular cardiomyocytes are predominantly coupled via Cx-43 gap junctions. Thus, the effect of AAP10 seen in these cells should also be observable in cells transfected with Cx43. Accordingly, in HeLa-rCx43 cells, which express Cx43 [13] , AAP10 exerted the same effects as those seen in cardiomyocytes. Thus, AAP10 seems to act on Cx43. It is well known that PKC activation can lead to phosphorylation of cardiac Cx43 [40] associated with both increased g j [35, 38, 41] and decreased g j [39, 42] . This might depend on the isoform of PKC that is activated, because Doble et al. [39] showed that the decrease in coupling following exposure to fibroblast growth factor depends on PKCε activation, and ---in our study ---the AAP10-induced increase in coupling seemed to depend on PKCα. This result suggested the hypothesis that AAP10 may lead to PKC-dependent phosphorylation of Cx43, which is supported by the finding of enhanced incorporation of 32 P in Cx43 (via autoradiography) and an increased ratio PCx43/NP-Cx43 (via Western blot) after AAP10 exposure. Because AAP10-induced Cx43 phosphorylation can be completely suppressed by BIM, PKC seems to be involved. In support of this idea, PKC ELISA data demonstrate that AAP10 enhanced PKC activity, especially PKCα, because this AAP10-induced activation of PKC could be completely inhibited by CGP54345. Thus, the present findings support the idea that AAP10 activates PKC, which phosphorylates Cx43, finally leading to the changes in g j . This is in line with other reports showing that activation of PKC, at least in certain cells (cardiac cells, SKHep1/Cx43 cells), can enhance gap junctional coupling [37-38, 41, 43] . The finding of complete inhibition of AAP10-induced PKC activation by CGP54345 further supports the notion that AAP10 activates PKCα. However, an action on PKCε (an isoform that is important in myocytes [39] ) cannot be completely ruled out, although activation of this isoform would decrease (and not increase as observed with AAP10) g j [39] .
Finally, if an agonist activates PKC, this activation is in most cases mediated by a G-proteincoupled membrane receptor. Thus, we wanted to find out whether this might also hold true for AAP10. For that purpose, a classical radioligand binding study was performed [26] ) with membranes of cardiomyocytes. We found a saturable binding with a K d in the nanomolar range, which thus agrees well with the EC 50 of about 5 nM determined in functional experiments in hearts [4] . The specificity was also demonstrated by displacement with biologically inactive derivatives of AAP10. However, because both peptides are chemically closely related to each other, and because 14 C has a low specific activity, the B max determined in these studies might be too high [26] and should thus be considered preliminary. However, at present, other substances are known to act in the same way as AAP10 or its derivatives. Thus, a further detailed determination of the receptor density should be carried out when other ligands for the receptor are available. Taken together, these experiments support the idea of a membrane protein serving as a receptor for the antiarrhythmic peptide AAP10. Finally, this idea is further corroborated by the finding of a 200-kDa membrane protein that binds to the agarose-N-AAP10 column (affinity chromatography) and the finding that labeled AAP10 (both FITC-labeled AAP10 and 14 C-AAP10) could be covalently bound with the cross-linker to a 200-kDa protein. We cannot say at the moment that both proteins are identical, and we were not as yet able to analyze the amino acid sequence. The problem is that the amount of protein was too small for sequencing. Thus, for final identification of the protein, further upscaled experiments with larger amounts of protein have to be carried out. This 200-kDa protein may be found to represent a part of the membrane receptor.
The idea of a membrane receptor for antiarrhythmic peptides is also supported by the finding that the AAP10-induced phosphorylation of Cx43 could be completely abolished by pretreatment of the cells with GDP-βS. Sensitivity to GDP-βS typically indicates G-protein-coupled signaling [44, 45] . Thus, the signaling cascade for AAP10 leading to PKC activation might involve a Gprotein.
In conclusion, AAP10 can 1) bind to a membrane protein, 2) activate PKC, 3) lead to PKCdependent phosphorylation of Cx43, and 4) lead to PKC-dependent enhancement of g j . The inhibitory effect of CGP54345 on AAP10 effects indicates that PKCα is involved. Thus, we postulate that AAP10 directly or indirectly (via a membrane receptor; this hypothesis is supported by the sensitivity to GDP-βS) activates PKC, leading to phosphorylation of Cx43, which results in enhanced g j . Further studies will be undertaken to elucidate this possible signaling cascade in more detail. Whereas one cell was held at -40 mV, the other was clamped to -90 to +10 mV, thereby establishing a transcellular potential ranging from -50 to 50 mV (see Fig. 1 ). The pulses are 200 ms in duration. Every 4 min gap junction conductance was assessed, so that the figure shows current traces over 60 min. B) Original registration of gap junction conductance in pairs of isolated guinea pig cardiomyocytes before and after application of 50 nmol/l AAP10. AAP10 was administered to the bath solution. Conditions as in (A). ; 10 µM, n=6) . In each series of experiments there was a 30 min control period (CON) followed by a 30 min treatment period with 50 nM AAP10. While AAP10 was applied extracellularly into the bath solution, the PKC inhibitors were given intracellularly via the pipettes (i.e., throughout the entire experiment). All values are given as means ± SE of n experiments. Significant differences versus the vehicle control are indicated by an asterisk; significant differences versus AAP10 alone are marked by a # (P<0.05). For more details see text. B) Changes in g j in transfected HeLa-Cx43 cells before and after addition of 50 nM AAP10. Note the rundown in g j during the control phase and the increase in g j after addition of AAP10, given quantitatively in the inset. A significant difference between the change in g j during control period and AAP10 treatment period is indicated by an asterisk (P<0.05). g j was assessed by establishing transjunctional voltages ranging from -50 to +50 mV by using pulses of 200 ms duration. C) Voltage-dependent inactivation of gap junction current given as G jss /G jinst ratio in transfecetd HeLa-Cx43 cells measured by application of pulses (duration: 5 s) establishing transjunctional volatges ranging from -100 to +100 mV before (filled squares) and after a 30 min treatment with 50 nM AAP10 (open circles). for methodological details see text) . The upper part of the figure shows the autoradiography indicating a radioactively labeled protein band at 200 kDa. The lower part of the figure shows a result obtained from affinity chromatography. An agarose column with bound AAP10 was used as the stationary phase and membrane proteins from rabbit ventricles were separated using this column. After 10 min incubation, the column was diluted with 10 ml saline (pH 7.4) followed by perfusion with saline at pH 6.5, collected in fractions of 1 ml (for more details see Methods). At 200 kDa a protein band was found in the elution fraction 5, and a smaller amount in the fractions 3 and 7.
